NSPR:NASDAQ, InspireMD, Inc.

Why NSPR stock fell on November 13

InspireMD, Inc. fell 16.9% on Friday, November 13, 2026, on 1,298,000 shares, 6.2 times its average daily volume. Headlines around the move:

NSPR stock overview

InspireMD, Inc. (NSPR:NASDAQ) closed at $0.650 on November 17, 2026, up 8.33% on the day. The stock trades 70.0% below its 52-week high of $2.17 and 51.2% above its 52-week low of $0.430. Over the past year, it lost 66.1%. InspireMD, Inc. is part of the Health Care sector.

Key figures

Price
$0.650
Day change
+8.33%
Volume
494,652
Average volume
207,735
Market cap
30M+
52-week range
$0.430 – $2.17
50-day average
$0.624
200-day average
$1.02

Price action over the past year

In 252 trading sessions since November 17, 2025, NSPR closed higher on 93 days (37%). Its best day was November 3, 2026 (+22.22%) and its worst was November 5, 2026 (-17.95%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

NSPR news

About InspireMD, Inc.

InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

Similar stocks

Find more stocks like NSPR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.